EUVIMEDEUVIMED entdecken
Crossref

The role of immune cells in mediating the effects and prognosis of lipidome in ER+ breast cancer: A mendelian randomization study

Journal of Chinese Pharmaceutical Sciences · 30.06.2026 · 35 (6) · 560

DOI: 10.5246/jcps.2026.06.040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Chinese Pharmaceutical Sciences, online erschienen am 10.06.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). The role of immune cells in mediating the effects and prognosis of lipidome in ER+ breast cancer: A mendelian randomization study. Journal of Chinese Pharmaceutical Sciences, 35(6), 560. https://doi.org/10.5246/jcps.2026.06.040

Vancouver

The role of immune cells in mediating the effects and prognosis of lipidome in ER+ breast cancer: A mendelian randomization study. Journal of Chinese Pharmaceutical Sciences. 2026;35(6):560. doi:10.5246/jcps.2026.06.040

BibTeX
@article{euvimed2026,
  title = {The role of immune cells in mediating the effects and prognosis of lipidome in ER+ breast cancer: A mendelian randomization study},
  journal = {Journal of Chinese Pharmaceutical Sciences},
  year = {2026},
  volume = {35},
  number = {6},
  pages = {560},
  doi = {10.5246/jcps.2026.06.040}
}
Kostenlos starten →